Axonex AI Group (AXNX) vs MoneyHero (MNY)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
MoneyHero is the larger company by market cap ($25.1 million vs $5.3 million), about 4.8 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | AXNX | MNY |
|---|---|---|
| Share price | $0.8301 | $0.56 |
| Market cap | $5.28M | $25.10M |
| 1-day change | -8.28% | 0.00% |
| YTD return | — | -55.56% |
| 1-year return | — | -54.47% |
| 5-year return | — | -94.32% |
| Forward P/E | — | 28.00 |
| EPS (TTM) | $-10.37 | $-0.30 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | — | $79.51M |
| Revenue growth (YoY) | — | -1.44% |
| Net income (latest FY) | $-10.31M | $37.79M |
| Gross margin | — | 41.92% |
| Operating margin | — | -50.55% |
| Net margin | — | 47.52% |
| 52-week high | $18.35 | $1.60 |
| 52-week low | $0.68 | $0.378 |
| Distance from 52-week high | -95.48% | -65.00% |
| Analyst consensus | hold | strong_buy |
| Avg. price target upside | — | +301.79% |
| Average volume | 2.01M | 27.59K |
| Shares outstanding | 6.08M | 31.57M |
| Employees | 797 | 240 |
| Sector | Consumer Discretionary | Consumer Discretionary |
| Industry | Business Services | Business Services |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- MoneyHero is about 4.8 times larger than Axonex AI Group by market value ($25.10M vs $5.28M).
About Axonex AI Group
AXNX stock →Axonics, Inc., a medical technology company, engages in the development and commercialization of novel products for the treatment of bladder and bowel dysfunction. Its sacral neuromodulation (SNM) systems are used to treat patients with overactive bladder (OAB), including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence (FI) and non-obstructive urinary retention (UR); and rechargeable (R20) and recharge-free (F15) implantable SNM systems that delivers mild electrical pulses to the targeted sacral nerve to restore normal communication to and from the brain to reduce the symptoms of OAB, UR, and FI.
Consumer Discretionary · Business Services · 797 employees
About MoneyHero
MNY stock →MoneyHero Limited operates a personal finance aggregation and comparison platform for banking, insurance, and other financial products. Its online financial comparison platform provides services for credit cards, personal loans, mortgages, wealth, insurance, and other financial products connecting the providers of these products with matched and ready-to-transact consumers.
Consumer Discretionary · Business Services · 240 employees
AXNX vs MNY FAQ
Which is bigger, Axonex AI Group or MoneyHero?
MoneyHero (MNY) is larger, with a market capitalization of $25.10M compared with $5.28M for Axonex AI Group (AXNX).
Are Axonex AI Group and MoneyHero in the same industry?
Yes. Both are classified in the Business Services industry within the Consumer Discretionary sector.